Good, broad review, includes IO and non-IO combos. One salient point only mentioned in regards to IO combination of anti-PD1 and OX40 is sequencing/order. As noted, many chemo combinations have little science behind them, and especially lacking here as well is dosing and sequence effects.

#CancerResearch #immunotherapy